A Novel Peptide Elabela is Associated with Hypertension-Related Subclinical Atherosclerosis.
HendrianusSuko AdiartoRadityo PrakosoIsman FirdausSuci IndrianiEstu RudiktyoBambang WidyantoroTaofan SiddiqAde Meidian AmbariRenan SukmawanPublished in: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension (2022)
This study demonstrated for the first time that circulating elabela declined in a higher stage of hypertension and hypertensive patients with increased carotid IMT, implicating that elabela may be involved in the pathogenesis of hypertension-associated subclinical atherosclerosis.